Medical Research Council Impact Acceleration Account IAA

Our aim is to build on the University of Kent's strong foundation in Biomedical and clinical research, and enable a step change in the activity, impact, and ultimate success of our translational research pipeline.

Best wishes

Michelle Garrett

Professor of Cancer Therapeutics and MRC IAA Lead

E: mrciaa@kent.ac.uk

Follow us on LinkedIn

MRC IAA objectives:

• Deliver a fast, flexible see-funding strategy for researchers
• Promote innovative forms of interaction and knowledge exchange between key translational stakeholders including industry, clinical and third sector organisations
• Provide training and mentoring to generate new translational research
• Develop new interdisciplinary consortia in areas of research strength at the University of Kent

Funding Opportunities

Rapid Response Fund (RRF) - Open call

To initiate or strengthen engagement with other stakeholders, for consortia building activities or training purposes.

• Applications can v=be submitted at any time
• Funding of up to £5,000 per project
• To apply, contact Michelle Garrett at mrciaa@kent.ac.uk

NEW for 2024: BBSRC/MRC IAA Harmonised funding call

The University of Kent BBSRC and MRC Impact Acceleration Accounts (IAA) are delighted to announce a new harmonised funding call for 2024.